drug
Lumify
Marketedupdated 6mo agoby $BLCO Bausch & Lomb Corp
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugCOMBIGAN37 co-mentions · 26 sources
- drugBRIMONIDINE TARTRATE33 co-mentions · 26 sources
- tagApproval32 co-mentions · 16 sources
- drugQOLIANA26 co-mentions · 19 sources
- drugbrimonidine19 co-mentions · 19 sources
- companyApotex Corp7 co-mentions · 3 sources
- tagRecall7 co-mentions · 7 sources
- drugtimolol maleate LA3 co-mentions · 3 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 9 investigational indications.
all catalysts(13)
approval · 13
May 22, 2006
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Oct 30, 2007
approval
$ABBV286.01-2.33%
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Aug 3, 2010
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Mar 27, 2012
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Oct 11, 2012
approval
$ABBV286.01-2.33%
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Sep 25, 2014
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Oct 15, 2015
approval
$ABBV286.01-2.33%
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Nov 10, 2015
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Jan 19, 2016
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Nov 21, 2025
approval
QOLIANA (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Mar 11, 2026
approval
BRIMONIDINE TARTRATE — FDA approval
Lumify
→
Mar 17, 2026
approval
$ABBV286.01-2.33%
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Apr 16, 2026
approval
BRIMONIDINE TARTRATE — FDA approval
Lumify
→
Trials studying Lumify
- phase2A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
- phase3Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
- phase3A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness
- phase3Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
- phase3Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
- phase2TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis
- phase3"Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness"
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 27, 2029
~2.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (14)
- Jun 13, 2031formulationUS 102015174.6y
- Jun 13, 2031formulationUS 80534274.6y
- Jun 13, 2031formulationUS 81637254.6y
- Mar 25, 2031formulationUS 85132474.3y
- Mar 25, 2031formulationUS 85132494.3y
- Mar 25, 2031method-of-use (U-1428)US 98616314.3y
- Mar 25, 2031method-of-use (U-1428)US 98616324.3y
- Jul 14, 2030method-of-use (U-2222)US 82937423.6y
- Jul 14, 2030method-of-use (U-2222)US 82937423.6y
- Jul 14, 2030method-of-use (U-2222)US 92594253.6y
- Jul 14, 2030method-of-use (U-2222)US 92594253.6y
- Jul 27, 2029method-of-use (U-2222)US 115966002.7y
- Jul 27, 2029method-of-use (U-2222)US 115966002.7y
- Jul 27, 2029method-of-use (U-2222)US 118332452.7y
News(2)
- Diagnostic Ultrasound System Correction: Philips Ultrasound Issues Updated Use Instructions for Lumify Diagnostic Ultrasound SystemA software app or transducer connection problem with the Philips Lumify diagnostic ultrasound system can result in loss of or delays in scanning functionality.fda_medwatch · 1mo ago
- Early Alert: Diagnostic Ultrasound System Issue from Philips UltrasoundA software app or transducer connection problem with the Philips Lumify diagnostic ultrasound system can result in loss of or delays in scanning functionality.fda_medwatch · 1mo ago
Data sources
last refreshed 7h ago
Found something off?
comments(0)
5-min edit window · permanent after that